Metabolic hijacking: A survival strategy cancer cells exploit?

Area of Science:

• Oncology
• Cancer Biology
• Metabolism

Background:

• Human tumors feature a complex microenvironment with epithelial cancer cells and cancer-associated fibroblasts (CAFs).
• CAFs are abundant mesenchymal cells in carcinomas, influencing tumor progression and metastasis.
• Epithelial cancer cells reprogram their metabolism to survive nutrient deprivation by utilizing CAF metabolic functions.

Purpose of the Study:

• To review the intricate metabolic interactions between epithelial cancer cells and CAFs.
• To elucidate the molecular mechanisms driving the pro-tumorigenic relationship between these cell types.
• To identify potential CAF-based therapeutic targets.

Main Methods:

• Literature review of studies on cancer cell metabolism and CAF interactions.
• Analysis of molecular mechanisms underlying metabolic reprogramming in cancer.
• Synthesis of current evidence on CAF roles in tumor progression, metastasis, and drug resistance.

Main Results:

• CAFs significantly contribute to tumor progression, metastasis, and chemotherapeutic resistance through metabolic crosstalk.
• Metabolic reprogramming allows cancer cells to exploit CAF metabolic capabilities for survival and growth.
• The precise molecular mechanisms of this interaction require further elucidation.

Conclusions:

• The metabolic interaction between cancer cells and CAFs is a critical factor in tumor development and treatment resistance.
• Targeting CAFs offers a promising strategy for novel cancer therapies.
• Further research into the molecular details of this crosstalk is essential for therapeutic development.